| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 755.00K | — |
| Operating expense | — | — |
| Net income | -8.10M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IRD returned +250.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +100.5% |
| 1 year | +250.4% |
| 5 years | -9.4% |
| 10 years | -96.6% |
| All-time high | $2,400.00 (Aug 2006) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in IRD would be worth today ›No. Opus Genetics, Inc. has not paid a dividend in the past 12 months.
Opus Genetics, Inc. stock trades on NASDAQ under the ticker symbol IRD.
Opus Genetics, Inc. is part of the Healthcare sector.
Opus Genetics, Inc. has a market cap of 335.28M USD, based on the latest quote.
